Publication | Open Access
Adoptive T cell therapy with TBI-1301 results in gene-engineered T cell persistence and anti-tumour responses in patients with NY-ESO-1 expressing solid tumours
10
Citations
0
References
2019
Year
Tbi-1301 ResultsCell TherapyMedicineImmunologySolid TumoursAnti-tumour ResponsesImmune Checkpoint InhibitorCell TransplantationImmune Cell TherapyImmunotherapyOncologyRadiation Oncology
No additional data available for this publication yet. Check back later!